Skip to main content
Premium Trial:

Request an Annual Quote

Susan Robinson, Stewart Parker, Barrie Carter

Premium
Targeted Genetics has appointed Susan Robinson as its president and CEO.
 
Robinson replaces Stewart Parker, who resigned last week. The company also said that CSO Barrie Carter has resigned, although a replacement has not been named.
 
Robinson had previously served as vice president of business development for Targeted Genetics. Before joining the company, she was director of business development at Genzyme Molecular Oncology.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more